Metformin is the basic drug in the clinical treatment of Diabetes, often used in the treatment of Type 2 Diabetes Mellitus (T2DM).Its effect has been fully verified in the clinical treatment of T2DM. However, in the treatment of T2DM with metformin, there is still a certain probability of related lactic acidosis, and the fatality rate is high. Therefore, is the use of metformin drug treatment a direct risk factor for lactic acidosis in diabetic patients? This paper will review the hypoglycemic mechanism of metformin and related studies on lactic acidosis, so as to further explore the relationship between metformin and lactic acidosis in diabetic patients, and provide help and reference for metformin drugs in the clinical treatment of T2DM
Metformin is an old drug which is widely prescribed for the treatment of type 2 diabetes mellitus (T...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
PURPOSE: Metformin can reduce diabetes-related complications and mortality. However, its use is limi...
<div><p>Background</p><p>Metformin constitutes first-line treatment of type 2 diabetes mellitus. It ...
Metformin is a dimethyl biguanide oral anti-hyperglycemic agent. Lactic acidosis due to metformin is...
International audienceIntroduction . To evaluate the strength of association between lactic acidosis...
Introduction. To evaluate the strength of association between lactic acidosis (LA) and well-recogniz...
Metformin is a widely used antihyperglycemic agent recommended by both the American Diabetes Associa...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin is a dimethyl biguanide oral anti-hyperglycemic agent. Lactic acidosis due to metformin is...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin is an old drug which is widely prescribed for the treatment of type 2 diabetes mellitus (T...
Metformin is an old drug which is widely prescribed for the treatment of type 2 diabetes mellitus (T...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
PURPOSE: Metformin can reduce diabetes-related complications and mortality. However, its use is limi...
<div><p>Background</p><p>Metformin constitutes first-line treatment of type 2 diabetes mellitus. It ...
Metformin is a dimethyl biguanide oral anti-hyperglycemic agent. Lactic acidosis due to metformin is...
International audienceIntroduction . To evaluate the strength of association between lactic acidosis...
Introduction. To evaluate the strength of association between lactic acidosis (LA) and well-recogniz...
Metformin is a widely used antihyperglycemic agent recommended by both the American Diabetes Associa...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin is a dimethyl biguanide oral anti-hyperglycemic agent. Lactic acidosis due to metformin is...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin is an old drug which is widely prescribed for the treatment of type 2 diabetes mellitus (T...
Metformin is an old drug which is widely prescribed for the treatment of type 2 diabetes mellitus (T...
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it r...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...